Position in PRGO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$144,379
-$15,925,281 QoQ
Shares Held
13,896
-99.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#209
of 334 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $670,557,120 across 30 Drug Manufacturers - Specialty & Generic names. PRGO ranks #30 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
923,125 | $155,583,487 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
249,056 | $134,946,012 | |
| 3 | ALKS |
Alkermes plc.
|
2,421,016 | $126,861,238 | |
| 4 | ZTS |
Zoetis Inc.
|
1,435,652 | $103,165,952 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,114,912 | $33,902,039 | |
| 6 | LQDA |
Liquidia Corp
|
301,432 | $24,033,173 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,120,469 | $11,204,690 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
614,206 | $10,631,905 |
All Filings in PRGO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $144,379 | 13,896 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $16,069,660 | 1,496,244 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $9,236,727 | 663,558 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,295,030 | 417,379 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,837,529 | 368,171 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $16,700,399 | 595,592 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $22,183,924 | 862,852 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $29,592,712 | 1,128,201 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $23,732,634 | 924,168 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $23,946,849 | 743,922 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $17,039,374 | 529,502 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,271,547 | 384,086 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,812,033 | 200,649 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $17,237,651 | 480,559 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,850,726 | 200,960 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $6,424,541 | 180,161 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,531,394 | 234,937 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,535,778 | 39,963 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,366,012 | 35,116 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,352,064 | 49,695 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $16,416,169 | 405,638 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $17,183,794 | 384,253 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $10,308,539 | 224,538 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $1,958,160 | 35,429 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $30,885,033 | 642,234 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||